| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G7I3H4 | Gamma-irradiation and mitomycin C induced protein, putative; | MTR_1g007950; | NULL | 517 | barrel-medic |
| G7KSB7 | DNA-directed RNA polymerase subunit beta; | MTR_7g069560; | XP_003623320.1; | 387 | barrel-medic |
| G7K0M3 | DNA helicase-like protein, putative; | MTR_5g098440; | XP_003618049.1; | 79 | barrel-medic |
| G7K8H6 | Toll interleukin receptor; | MTR_5g092500; | XP_003617518.1; | 82 | barrel-medic |
| G7KNL3 | COP9 signalosome complex subunit-like protein; | MTR_6g023350; | XP_003618818.1; | 425 | barrel-medic |
| G7LHN5 | DUF239 domain protein; | MTR_8g040850; | NULL | 393 | barrel-medic |
| G7LBX3 | Uncharacterized protein; | MTR_8g058260; | XP_003628440.1; | 69 | barrel-medic |
| G7JN70 | SCF ubiquitin ligase, SKP1 component; | MTR_4g032450; | XP_003605510.1; | 175 | barrel-medic |
| G7JA19 | Zinc ion-binding protein; | MTR_3g069410; | NULL | 513 | barrel-medic |
| G7IRT8 | Uncharacterized protein; | MTR_2g094530; | XP_003597253.1; | 144 | barrel-medic |
| G7JAW9 | Chaperone DnaJ domain protein; | MTR_3g095470; | NULL | 273 | barrel-medic |
| G7LC63 | Crossover junction endonuclease EME1; | MTR_8g092300; | NULL | 568 | barrel-medic |
| G7IIW2 | Nodule Cysteine-Rich (NCR) secreted peptide; | MTR_2g049575; | XP_003595575.1; | 55 | barrel-medic |
| G7IFN8 | Methionine sulfoxide reductase B; | MTR_2g020900; | XP_003594062.1; | 149 | barrel-medic |
| G7IM94 | Uncharacterized protein; | MTR_2g084190; | XP_003596729.1; | 62 | barrel-medic |
| G7J619 | RNA recognition motif (RRM) containing protein; | MTR_3g079310; | NULL | 928 | barrel-medic |
| G7ISM5 | Enhancer of mRNA-decapping-like protein; | MTR_2g027690; | NULL | 1378 | barrel-medic |
| G7JXA9 | Transmembrane protein, putative; | MTR_5g058020; | XP_003614707.1; | 102 | barrel-medic |
| G7JVP7 | HXXXD-type acyl-transferase family protein; | MTR_4g022720; | XP_003605002.1; | 436 | barrel-medic |
| G7JWK6 | Uncharacterized protein; | MTR_5g042630; | XP_003613920.1; | 383 | barrel-medic |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |